Krystal Biotech Announces Up To $400M Buyback Program, Expects Repurchases Over Next Two Years
Share
Why It Matters
Krystal Biotech said it will buy back its own stock over two years. When a company buys its own stock, it can mean the leaders think the stock price is good right now.
This read is generated by AI from raw market data and is for education only. It is not financial advice, not a signal, and not a recommendation to buy or sell.
Source: Benzinga · Read the original report at the publisher. Headline and figures shown for context; data may be delayed.
Disclosure: Educational and informational purposes only. Not financial advice. We educate, not advise. Market data may be delayed up to 15 minutes unless marked real-time. Past performance is not indicative of future results.